Ordenar

Buscar

01/02/2026 Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient
Montero-Garcia, A, Pérez-Garcia, G, Cobo-De-Nadal, M, Verdú-Reyes, A, Díaz-Cascajosa, J. Corticosteroid-responsive optic neuritis associated with acute retinal necrosis due to Herpes simplex virus type 2 in a pediatric patient. JOURNAL FRANCAIS D OPHTALMOLOGIE. 2026; 49(2)DOI:10.1016/j.jfo.2025.104760. PMID:41512673. IF:1.100(Q3/8D).
01/02/2026 Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort
Ardébol, SB, Pérez-Pastor, GM, Fernández-de-Misa, R, Botella-Estrada, R, Ruiz-Salas, V, Flórez, A, Arenal, MM, González, MJF, Bassas-Freixas, P, Toll, A, Almazán, PV, Arntz, R, Malvehy, J. Postauthorization Safety Study (NISSO) Assessing the Long-Term Safety Profile of Sonidegib in Patients With Locally Advanced Basal Cell Carcinoma: Interim Analysis From the Spanish Cohort. Actas Dermo-Sifiliograficas. 2026; 117(2)DOI:10.1016/j.ad.2025.104524. PMID:41352588. IF:(Q/D).
01/02/2026 Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review
Baniandres, O, Franch, IB, Rull, EV, Moya, AI, Pacheco, MLA, Puchades, AM, Sánchez, JPH, Diaz, FJM, Ruiz, AB, Cantero, AG, Lorenzo, EM, Gutierrez, MG, Fernández-Freire, LR, Payeras, AV, Santos, CM, Bel, PH, Ostiz, SH, Montcusi, JP, Salafranca, MA, Segura, PC, Pallas, IM, Masoliver, AA, Manchón, TM, Mucientes, CD, Apetrei, CLS, Martinez, AB, Serrano, JM, Ortega, CP, del Cura, LR, Barragán, IL, Mur, EC, Olivares, MG, Dobao, PD. Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70053. PMID:40931458. IF:3.200(Q1/3D).
01/02/2026 Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors
Ara-Martín, M, Moreno, C, Ruiz-Villaverde, R, Serra-Baldrich, E, Hernández-Martín, I, Fortes, MD. Vaccination Recommendations in Patients With Atopic Dermatitis Treated With JAK Inhibitors. INTERNATIONAL JOURNAL OF DERMATOLOGY. 2026; 65(2)DOI:10.1111/ijd.70033. PMID:40928003. IF:3.200(Q1/3D).
01/02/2026 Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer
Afferi, L, Territo, A, Gallioli, A, Verri, P, Basile, G, Uleri, A, Cannoletta, D, Casadevall, M, Diana, P, Gavrilov, P, Arce, Y, Gaya, JM, Palou, J, Arrea, FA, Breda, A. Ex-vivo digital pathological imaging with the Vivascope confocal microscopy for intraoperative diagnostics during ureterorenoscopy for upper tract urothelial cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(2)DOI:10.1016/j.urolonc.2025.11.009. PMID:41372082. IF:2.300(Q2/5D).
01/02/2026 The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study
Batista, FD, Carcamo, PM, Nelson, E, Neto, ABD, Tsuha, DH, Lahdo, V, dos Santos, VR, Ribeiro, GS, Lopes, RD, Amadeu, P, Blanco, MVFM, da Costa, TR, Chalegre, KDD, Riback, TIS, da Silva, CC, Ranzani, OT, Cummings, DAT, Andrews, JR, Ko, AI, Hitchings, MDT, Anders, KL, Moreira, LA, Gonçalves, CCM, Croda, J. The impact of large-scale release of Wolbachia mosquitoes on dengue incidence in Campo Grande, Brazil: an ecological study. Lancet Regional Health-Americas. 2026; 54DOI:10.1016/j.lana.2025.101327. PMID:41438239. IF:(Q/D).
01/02/2026 Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study
Buchmeier, EL, Reck, M, Girard, N, Nadal, E, Gay, CM, Filippi, AR, Martin, LW, Petersen, C, Cairns, DA, Roch, B, Attili, I, Alvarez, RA, Boyer, A, Tarruella, MM, Robinson, A, Levra, MG, Li, L, Perez, ID, Georgoulia, N, Spicer, J. Neoadjuvant (neoadj) durvalumab (D) plus chemotherapy (CT) followed by either surgery (Sx) and adjuvant D or CRT and consolidation D in patients (pts) with resectable or borderline resectable stage IIB-IIIB NSCLC: interim analysis (IA) of the phase 2 MDT-BRIDGE study. Oncology Research and Treatment. 2026; 49DOI:. PMID:. IF:1.600(Q4/9D).
01/02/2026 International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease
Giani, C, Baldi, GG, Ljevar, S, Denu, RA, Andelkovic, V, Han, I, Brunello, A, Napolitano, A, Bhadri, VA, Scanferla, R, Garcia, AS, Abreu, MH, Campos, F, Ogura, K, Wong, DD, Bae, S, Marquina, G, Mazzocca, A, Yang, V, Nakazawa, MS, Kim, HS, Chiusole, B, Thway, K, Antonescu, C, Bellan, E, Bovée, JVMG, Davis, JL, Tos, APD, Di Blasi, E, Lazar, AJ, Sbaraglia, M, Schaefer, IM, Taverna, S, Chen, TWW, Miceli, R, Gronchi, A, Stacchiotti, S. International multicenter retrospective study on pleomorphic rhabdomyosarcoma (P-RMS), a PUSH platform study: outcome of primary localized disease. ESMO Open. 2026; 11(2)DOI:10.1016/j.esmoop.2025.106044. PMID:41564817. IF:8.300(Q1/2D).